HNRNPA1L3
gene geneOn this page
Summary
HNRNPA1L3 (heterogeneous nuclear ribonucleoprotein A1 like 3, HGNC:48778) is a protein-coding gene on chromosome 16q12.1, encoding Heterogeneous nuclear ribonucleoprotein A1-like 3 (A0A2R8Y4L2).
Predicted to enable RNA binding activity. Predicted to be involved in mRNA splicing, via spliceosome. Predicted to be located in nucleus. Predicted to be part of catalytic step 2 spliceosome.
Source: NCBI Gene 642659 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001396241
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:48778 |
| Approved symbol | HNRNPA1L3 |
| Name | heterogeneous nuclear ribonucleoprotein A1 like 3 |
| Location | 16q12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000224578 |
| Ensembl biotype | protein_coding |
| Entrez | 642659 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000565308, ENST00000698152
RefSeq mRNA: 1 — MANE Select: NM_001396241
NM_001396241
CCDS: CCDS92159
Canonical transcript exons
ENST00000698152 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003972857 | 51645757 | 51647079 |
Expression profiles
Bgee: expression breadth ubiquitous, 133 present calls, max score 88.61.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 1.7396 / max 32.5324, expressed in 1048 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 154046 | 1.7396 | 1048 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ganglionic eminence | UBERON:0004023 | 88.61 | gold quality |
| cortical plate | UBERON:0005343 | 87.56 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.25 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.91 | gold quality |
| ventricular zone | UBERON:0003053 | 82.27 | gold quality |
| bone marrow cell | CL:0002092 | 81.95 | gold quality |
| bone marrow | UBERON:0002371 | 79.98 | gold quality |
| ovary | UBERON:0000992 | 78.64 | gold quality |
| left ovary | UBERON:0002119 | 78.00 | gold quality |
| vermiform appendix | UBERON:0001154 | 77.68 | gold quality |
| duodenum | UBERON:0002114 | 77.32 | gold quality |
| tonsil | UBERON:0002372 | 77.13 | gold quality |
| placenta | UBERON:0001987 | 76.31 | gold quality |
| right ovary | UBERON:0002118 | 75.29 | gold quality |
| stromal cell of endometrium | CL:0002255 | 74.14 | gold quality |
| leukocyte | CL:0000738 | 73.61 | gold quality |
| monocyte | CL:0000576 | 73.59 | gold quality |
| endometrium | UBERON:0001295 | 72.90 | gold quality |
| islet of Langerhans | UBERON:0000006 | 72.45 | gold quality |
| urinary bladder | UBERON:0001255 | 72.41 | gold quality |
| uterine cervix | UBERON:0000002 | 72.26 | gold quality |
| lymph node | UBERON:0000029 | 71.99 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 71.69 | gold quality |
| granulocyte | CL:0000094 | 71.67 | gold quality |
| ectocervix | UBERON:0012249 | 71.66 | gold quality |
| body of uterus | UBERON:0009853 | 71.38 | gold quality |
| myometrium | UBERON:0001296 | 71.27 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 70.90 | gold quality |
| mucosa of stomach | UBERON:0001199 | 70.88 | gold quality |
| pancreas | UBERON:0001264 | 70.79 | gold quality |
Single-cell (SCXA)
Detected in 10 experiment(s), a significant marker in 6.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-124472 | yes | 1241.77 |
| E-MTAB-6701 | yes | 544.92 |
| E-HCAD-10 | yes | 35.63 |
| E-ANND-3 | yes | 19.25 |
| E-GEOD-125970 | yes | 14.63 |
| E-GEOD-135922 | yes | 10.75 |
| E-CURD-79 | no | 582.59 |
| E-MTAB-8221 | no | 305.12 |
| E-GEOD-93593 | no | 8.60 |
| E-MTAB-5061 | no | 3.87 |
Regulation
Is transcription factor: no
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | hnrnpa1b | ENSDARG00000036675 |
Paralogs (36): DAZAP1 (ENSG00000071626), CIRBP (ENSG00000099622), RBM23 (ENSG00000100461), RBM3 (ENSG00000102317), NCL (ENSG00000115053), TIA1 (ENSG00000116001), HNRNPA2B1 (ENSG00000122566), RBM19 (ENSG00000122965), RBM39 (ENSG00000131051), MSI1 (ENSG00000135097), HNRNPA1 (ENSG00000135486), HNRNPD (ENSG00000138668), HNRNPA1L2 (ENSG00000139675), RBMX (ENSG00000147274), A1CF (ENSG00000148584), TIAL1 (ENSG00000151923), RBM46 (ENSG00000151962), HNRNPDL (ENSG00000152795), MSI2 (ENSG00000153944), RBM47 (ENSG00000163694), RBMY1F (ENSG00000169800), HNRNPA3 (ENSG00000170144), RBMXL2 (ENSG00000170748), RBM4B (ENSG00000173914), RBM4 (ENSG00000173933), RBMXL3 (ENSG00000175718), HNRNPA0 (ENSG00000177733), TRNAU1AP (ENSG00000180098), HNRNPAB (ENSG00000197451), RBMXL1 (ENSG00000213516), RBMY1J (ENSG00000226941), RBMY1A1 (ENSG00000234414), RBMY1E (ENSG00000242389), RBMY1B (ENSG00000242875), RBMY1D (ENSG00000244395), DND1 (ENSG00000256453)
Protein
Protein identifiers
Heterogeneous nuclear ribonucleoprotein A1-like 3 — A0A2R8Y4L2 (reviewed: A0A2R8Y4L2)
Alternative names: Heterogeneous nuclear ribonucleoprotein A1 pseudogene 48
All UniProt accessions (1): A0A2R8Y4L2
RefSeq proteins (1): NP_001383170* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000504 | RRM_dom | Domain |
| IPR012677 | Nucleotide-bd_a/b_plait_sf | Homologous_superfamily |
| IPR021662 | HnRNPA1/A2_C | Domain |
| IPR034516 | hnRNPA1/3_RRM2 | Domain |
| IPR034845 | hnRNPA1_RRM1 | Domain |
| IPR035979 | RBD_domain_sf | Homologous_superfamily |
Pfam: PF00076, PF11627
UniProt features (7 total): domain 2, region of interest 2, compositionally biased region 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A2R8Y4L2-F1 | 73.41 | 0.50 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 27 (showing top):
GOBP_RNA_SPLICING, GOCC_CATALYTIC_STEP_2_SPLICEOSOME, GOCC_SPLICEOSOMAL_COMPLEX, GOCC_RIBONUCLEOPROTEIN_COMPLEX, GOMF_MRNA_BINDING, GOMF_MRNA_3_UTR_BINDING, GOBP_MRNA_PROCESSING, MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS, HU_FETAL_RETINA_RPC, DESCARTES_FETAL_LUNG_CSH1_CSH2_POSITIVE_CELLS, GOCC_NUCLEAR_PROTEIN_CONTAINING_COMPLEX, BDP1_TARGET_GENES, HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL, HE_LIM_SUN_FETAL_LUNG_C0_EARLY_FIBROBLAST, HE_LIM_SUN_FETAL_LUNG_C0_EARLY_MESOTHELIAL_CELL
GO Biological Process (1): mRNA splicing, via spliceosome (GO:0000398)
GO Molecular Function (3): mRNA 3’-UTR binding (GO:0003730), nucleic acid binding (GO:0003676), RNA binding (GO:0003723)
GO Cellular Component (2): catalytic step 2 spliceosome (GO:0071013), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1 |
| mRNA processing | 1 |
| mRNA binding | 1 |
| binding | 1 |
| nucleic acid binding | 1 |
| Prp19 complex | 1 |
| spliceosomal complex | 1 |
| U5 snRNP | 1 |
| catalytic complex | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1416 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HNRNPA1L3 | CHRNA1 | P02708 | 349 |
| HNRNPA1L3 | PLD5 | Q8N7P1 | 349 |
| HNRNPA1L3 | PNPLA8 | Q9NP80 | 348 |
| HNRNPA1L3 | RAVER1 | Q8IY67 | 348 |
| HNRNPA1L3 | MATR3 | P43243 | 340 |
| HNRNPA1L3 | PRSS21 | Q9Y6M0 | 335 |
| HNRNPA1L3 | FUNDC2 | Q9BWH2 | 335 |
| HNRNPA1L3 | RPL10A | P52859 | 335 |
| HNRNPA1L3 | DOCK1 | Q14185 | 331 |
| HNRNPA1L3 | MAP3K7CL | P57077 | 306 |
| HNRNPA1L3 | RAB28 | P51157 | 305 |
| HNRNPA1L3 | PTTG1 | O95997 | 291 |
| HNRNPA1L3 | CSMD3 | Q7Z407 | 285 |
| HNRNPA1L3 | TACSTD2 | P09758 | 284 |
| HNRNPA1L3 | RAB30 | Q15771 | 267 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0A0LLY1, A0A2R8Y4L2, A5A6H4, O89086, O93235, P04256, P09651, P09867, P10979, P17130, P21522, P27484, P49310, P49311, P49312, P51968, P51989, P51991, P51992, P60824, P60825, P60826, P98179, Q03250, Q03251, Q03878, Q05966, Q13151, Q14011, Q28521, Q28IQ9, Q2HJ60, Q32P51, Q38896, Q41188, Q43472, Q5RF83, Q61B10, Q6URK4, Q8BG05
Diamond homologs: A0A0A0LLY1, A0A0D1C8Z4, A0A2R8Y4L2, A5A6H4, A5A6M3, A7VJC2, D4AE41, O22703, O75526, O88569, O89086, O93235, P04256, P09651, P09867, P10979, P17130, P19682, P19683, P19684, P22626, P28644, P38159, P39697, P41891, P49310, P49311, P49312, P49313, P49314, P51968, P51989, P51990, P51991, P51992, P60824, P60825, P60826, P84586, P98179
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1002130810 (16:51644353 G>A), RS1002445447 (16:51643828 C>T), RS1002738459 (16:51645486 T>G), RS1006227606 (16:51644265 T>C), RS1006302959 (16:51644121 G>A,C), RS1007530833 (16:51647526 C>T), RS1008061135 (16:51647258 T>A,C), RS1009030653 (16:51645816 T>C), RS1009364341 (16:51644692 A>G), RS1010374625 (16:51644686 T>C,G), RS1011384297 (16:51647151 A>C,G), RS1011500941 (16:51645552 T>A,C), RS1013232535 (16:51645309 T>C), RS1013258974 (16:51645079 G>A), RS1013341196 (16:51646016 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | decreases expression | 1 |
| bisphenol A | decreases expression | 1 |
| ochratoxin A | affects cotreatment, decreases expression | 1 |
| Citrinin | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.